A Phase II study of selinexor plus cytarabine and idarubicin in patients with relapsed/refractory acute myeloid leukaemia.
BRITISH JOURNAL OF HAEMATOLOGY(2020)
Key words
acute myeloid leukaemia,clinical studies,chemotherapy,selinexor
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined